By including Flexi-Seal™ FMS as part of your patient care protocol, you can help reduce the costly complications caused by exposure to fecal waste. In fact, the often non-reimbursable cost of complications, such as pressure ulcers and nosocomial infections, can be considerably higher than the increased cost of consumables.1,2
Designed to help reduce the risk of skin breakdown and spread of infection that can lead to extended length of stay and increased treatment costs.1,2,6
For more information or to order samples, please contact our customer relations center at 1-800-465-6302.
1 O’Brien JA, Lahue BJ, Caro JJ, Davidson DM. The emerging infectious challenge of Clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. Infect Control Hosp Epidemiol. 2007:28(11):1219-1227.
2 Zhan C, Miller MR. Excess length of stay, charges and mortality attributable to medical injuries during hospitalization. JAMA. 2003;290(14):1868-1874.
3 HPIS. Q2 2011 data. Moving Annual Total (MAT) Fecal Control Category. Data on file, ConvaTec.
4 HCAI Technology Innovation Programme Showcase Hospitals report number 5. The Flexi-Seal® Fecal Management System. http://hcai.dh.gov.uk/files/2011/03/Evaluation_Report_Flexi_seal_faecal_management_system_HCAI_technologies_Dec09.pdf. Date accessed November 2011.
5 Keller BP, Wille J, van Ramshorst B, van der Werken C. Pressure ulcers in intensive care patients: a review of risks and prevention. Intensive Care Med. 2002;28(10):1379-1388.
6 Kyne L, Hamel MB, Polavaram R, Kelly CP. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. CID, 2002;34:346-53.
7 Popovich-Durnal A, Kommala D, Chen, Y. Budget Impact of Adopting a Fecal Management System in a Hospital Intensive Care Unit: A Single Center Experience. Poster presented at the Symposium on Advanced Wound Care Fall, Washington DC, September 2009.
*Compared to traditional fecal incontinence management